ATE316153T1 - Diagnose des persönlichen risikos zur entwicklung von diabetischer retinopathie - Google Patents

Diagnose des persönlichen risikos zur entwicklung von diabetischer retinopathie

Info

Publication number
ATE316153T1
ATE316153T1 AT00914228T AT00914228T ATE316153T1 AT E316153 T1 ATE316153 T1 AT E316153T1 AT 00914228 T AT00914228 T AT 00914228T AT 00914228 T AT00914228 T AT 00914228T AT E316153 T1 ATE316153 T1 AT E316153T1
Authority
AT
Austria
Prior art keywords
development
diabetic retinopathy
diagnosis
diseases
increased risk
Prior art date
Application number
AT00914228T
Other languages
English (en)
Inventor
Markku Koulu
Matti Karvonen
Ullamari Pesonen
Matti Uusitupa
Original Assignee
Hormos Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Corp filed Critical Hormos Medical Corp
Application granted granted Critical
Publication of ATE316153T1 publication Critical patent/ATE316153T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
AT00914228T 1999-04-15 2000-03-29 Diagnose des persönlichen risikos zur entwicklung von diabetischer retinopathie ATE316153T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/291,994 US6312898B1 (en) 1999-04-15 1999-04-15 Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene

Publications (1)

Publication Number Publication Date
ATE316153T1 true ATE316153T1 (de) 2006-02-15

Family

ID=23122742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00914228T ATE316153T1 (de) 1999-04-15 2000-03-29 Diagnose des persönlichen risikos zur entwicklung von diabetischer retinopathie

Country Status (17)

Country Link
US (2) US6312898B1 (de)
EP (1) EP1169475B1 (de)
JP (1) JP2003521473A (de)
AT (1) ATE316153T1 (de)
AU (1) AU777917B2 (de)
CA (1) CA2363994A1 (de)
CZ (1) CZ20013549A3 (de)
DE (1) DE60025595T2 (de)
EE (1) EE200100533A (de)
ES (1) ES2251977T3 (de)
HU (1) HUP0200719A3 (de)
NO (1) NO20014969D0 (de)
NZ (1) NZ513189A (de)
PL (1) PL350620A1 (de)
RU (1) RU2238107C2 (de)
WO (1) WO2000063430A1 (de)
ZA (1) ZA200104775B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050107327A1 (en) * 1997-12-19 2005-05-19 Hormos Medical Corporation Method for reducing overproduction of neuropeptide Y in an individual
BR0107845A (pt) * 2000-03-21 2002-10-22 Hormos Medical Corp Diagnóstico do risco de uma pessoa desenvolver alcoolismo
US20040254131A1 (en) * 2003-06-16 2004-12-16 Markku Koulu Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels
US6979294B1 (en) * 2002-12-13 2005-12-27 California Institute Of Technology Split-screen display system and standardized methods for ultrasound image acquisition and processing for improved measurements of vascular structures
WO2005052593A1 (en) * 2003-10-29 2005-06-09 The University Of Leicester Detection
KR100961926B1 (ko) * 2007-08-30 2010-06-10 서울대학교산학협력단 당뇨병성 망막병증 검출용 바이오 마커 조성물 및 진단키트
ES2337115B2 (es) * 2007-09-26 2011-01-24 Universidade De Santiago De Compostela Metodo para la deteccion del riesgo de desarrollar vitreorretinopatiaproliferante (vrp).
US20100225239A1 (en) * 2009-03-04 2010-09-09 Purespectrum, Inc. Methods and apparatus for a high power factor, high efficiency, dimmable, rapid starting cold cathode lighting ballast
RU2465598C1 (ru) * 2011-09-07 2012-10-27 Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования риска развития диабетической ретинопатии при сахарном диабете типа 2 у якутов
RU2461005C1 (ru) * 2011-09-07 2012-09-10 Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования риска развития диабетической ретинопатии при сахарном диабете типа 2 у якуток
RU2533836C1 (ru) * 2013-09-25 2014-11-20 Государственное бюджетное образовательное учреждение высшего профессионального образования Воронежская государственная медицинская академия имени Н.Н. Бурденко Министерства здравоохранения Российской Федерации (ГБОУ ВПО ВГМА им. Н.Н. Бурденко Минздрава России) Способ мониторинга лиц с риском раннего развития атеросклероза и наличием сахарного диабета 2 типа

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455164A (en) 1989-11-03 1995-10-03 Mcgill University Ruminant immortalized mammary epithelial cell lines
US5714497A (en) * 1993-02-15 1998-02-03 Sanofi Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
GB9406974D0 (en) 1994-04-08 1994-06-01 Pharmaceutical Proteins Ltd Transgenic production
GB9708918D0 (en) 1997-05-01 1997-06-25 Ppl Therapeutics Scotland Ltd Methods
SE9703414D0 (sv) * 1997-09-23 1997-09-23 Astra Ab New compounds

Also Published As

Publication number Publication date
ZA200104775B (en) 2002-06-12
PL350620A1 (en) 2003-01-27
CZ20013549A3 (cs) 2002-04-17
JP2003521473A (ja) 2003-07-15
NZ513189A (en) 2003-05-30
NO20014969L (no) 2001-10-12
US6312898B1 (en) 2001-11-06
ES2251977T3 (es) 2006-05-16
NO20014969D0 (no) 2001-10-12
CA2363994A1 (en) 2000-10-26
AU777917B2 (en) 2004-11-04
HUP0200719A3 (en) 2004-11-29
WO2000063430A1 (en) 2000-10-26
EP1169475B1 (de) 2006-01-18
HUP0200719A2 (en) 2002-06-29
DE60025595T2 (de) 2006-11-16
EP1169475A1 (de) 2002-01-09
EE200100533A (et) 2002-12-16
AU3563200A (en) 2000-11-02
DE60025595D1 (de) 2006-04-06
US20050234008A1 (en) 2005-10-20
RU2238107C2 (ru) 2004-10-20

Similar Documents

Publication Publication Date Title
Westman et al. Noise and stress: a comprehensive approach
IL154794A0 (en) Remedies for heart failure
DE60025595D1 (de) DIAGNOSE DES PERSöNLICHEN RISIKOS ZUR ENTWICKLUNG VON DIABETISCHER RETINOPATHIE
DE60314236D1 (de) Verfahren zur diagnose und therapie von schizophrenie
Call et al. Combined antecedent variables as motivating operations within functional analyses
Rennie et al. Refinement of the use of non-human primates in scientific research. Part I: the influence of humans
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
Hepler Women in labor: Mothers, medicine, and occupational health in the United States, 1890-1980
RU2001130755A (ru) Диагностика риска развития у субъекта атеросклероза или диабетической ретинопатии
Gulzar et al. Child labour: a public health issue
BG106583A (en) Diagnosis of a person's risk of developing alcoholism
Adams et al. Biosafety
GB2431348A (en) Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders
Panakal An Agenda for Criminology
Stephens Alternative to Current Uses of Animals in Research, Safety Testing, and Education: A Layman's Guide
Jarvis " Secrecy Has No Excuse": The Florida Land Boom, Tourism, and the 1926 Smallpox Epidemic in Tampa and Miami
Mondal COVID-19: BLESSING FOR ENVIRONMENT
ATE397090T1 (de) Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen
Vetri Animal research and shelter animals: An historical analysis of the pound animal controversy
Lamborn Social Control Through the Reconstitution of Man
Henry BSS: Tracking trends in sexual behavior
Jarvis " Secrecy Has No Excuse": The Florida Land Boom, Tourism, and the 1926 Smallpox Epidemic in Tampa and Miami
IN-HOME OUT-OF-HOME SERVICES
Wilson PART VI
Thomas Antimony: The use, rights, and regulation of laboratory animals

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties